{"nct_id":"NCT02694822","title":"AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2016-04","start_date_type":"ACTUAL","primary_completion_date":"2022-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-31","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["AGEN"]}